Tel Aviv, Israel: Patients suffering from Tourette syndrome (TS) report symptomatic benefits following the use of medical cannabis, according to data published in the journal Parkinsonism and Related Disorders.
Israeli researchers surveyed 42 patients with TS who had approval from the Health Ministry to use medical marijuana. Subjects typically reported reduced tic severity, better sleep, and improved mood following cannabis administration. About 75 percent of total participants elected to continue using cannabis long-term. Those who ceased their use did so because of a lack of perceived efficacy or due to side-effects.
Authors concluded: “MC (medical cannabis) seems to hold promise in the treatment of GTS (Gilles de la Tourette syndrome) as it demonstrated high subjective satisfaction by most patients.”
For more information, contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, “Single center experience with medical cannabis in Gilles de la Tourette syndrome,” appears in Parkinsonism and Related Disorders. NORML’s literature review on cannabis and Tourette Syndrome is online.